Podcast Episodes
Back to Search
PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Aust…
2 years, 6 months ago
Discussing Rheumatology: November 2023
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology. In this episode, he disc…
2 years, 6 months ago
ACR 2023 Highlights: Day 4
Join Sofia Ramiro as she goes through our top abstracts, posters, and presentations from Day 4 of ACR 2023 today (Wednesday 15 November). They're all…
2 years, 6 months ago
ACR 2023 Highlights: Day 3
Join Grace Wright as she goes through our top abstracts, posters, and presentations from Day 3 of ACR 2023 today (Tuesday 14 November). They're all a…
2 years, 6 months ago
ACR 2023 Highlights: Day 2
Join Laura Coates as she goes through our top abstracts, posters, and presentations from Day 2 of ACR 2023 today (Monday 13 November). They're all av…
2 years, 6 months ago
ACR 2023 Highlights: Day 1
Join Iain McInnes as he goes through our top abstracts, posters, and presentations from Day 1 of ACR 2023 today (Sunday 12 November). They're all ava…
2 years, 6 months ago
ACR 2023 Preview Podcast
Join Dr Sofia Ramiro as she previews our highlights this ACR, introducing some of the top abstracts and posters we’ve chosen so that you can better p…
2 years, 6 months ago
Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Aust…
2 years, 7 months ago
axSpA Podcast: Safety and Efficacy of Upadacitinib
Professor Hideto Kameda, Professor of Internal Medicine at Toho University in Japan, is joined by Professor Xenofon Baraliakos, Professor of Internal…
2 years, 7 months ago
CSF Author Interview: Dr. David Martin, 2023
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr. David Martin, executive medical director at Pfizer in Massachusetts, USA …
2 years, 7 months ago